Acute safety assessment of lithium bioacummulated in mycelial biomass of Ganoderma lucidum

Autores

  • Gustavo Ratti da Silva
  • Eduarda Carolina Amaral
  • Maria Luiza Marchi Silva
  • Aniely Oliveira Silva
  • Leila Isabel da Silva
  • Diego Lacir Froehlich Paranaense University, Umuarama, Paraná, Brazil
  • Maria Graciela Iecher Faria
  • Giani Andrea Linde
  • Nelson Barros Colauto
  • Evellyn Claudia Wietzikoski Lovato
  • Francislaine Aparecida dos Reis Lívero Universidade Paranaense

DOI:

https://doi.org/10.53660/CONJ-644-611

Palavras-chave:

Basidiomycetes, Bipolar disorder, Depression, Mania, Mushroom

Resumo

Lithium is a first-line treatment for bipolar disorder, a disorder that is characterized by alternating manic and depressive episodes. However, because of its narrow therapeutic index, lithium can cause adverse effects. The association of lithium with more complex molecules, such as proteins and polysaccharides, may help control the release of lithium throughout the digestive system, thereby reducing the doses that are used by patients and consequently reducing adverse effects. The present study evaluated the acute oral toxicity of lithium bioaccumulated in mycelial biomass of Ganoderma lucidum, a research step that precedes preclinical efficacy studies. The study followed Organization for Economic Cooperation and Development guideline. Male Wistar rats (n = 6) were acutely treated by gavage with fixed doses (300 and 2000 mg/kg) of lithium bioaccumulated in mycelial biomass of G. lucidum. Changes in clinical signs, body mass, relative organ mass, biochemical parameters, blood count, leukocytes, and histopathological changes were evaluated. A group of animals that were treated with vehicle (n = 6) served as the basal group. No signs of toxicity were observed in any of the investigated parameters. Lithium bioaccumulation in mycelial biomass of G. lucidum did not induce signs of toxicity in rats that were acutely orally treated.

Downloads

Não há dados estatísticos.

Referências

ADENEYE, A. A. et al. Preliminary toxicity and phytochemical studies of the stem bark aqueous extract of Musanga cecropioides in rats. Journal of ethnopharmacology, v. 105, n. 3, p. 374-379, 2006.

AIDA, F. M. N. A. et al. Mushroom as a potential source of prebiotics: a review. Trends in Food Science & Technology, v. 20, n. 11-12, p. 567-575, 2009.

ALBERT, U. et al. Lithium treatment and potential long-term side effects: a systematic review of the literature. Rivista di Psichiatria, v. 49, n. 1, p. 12-21, 2014.

ALMEIDA, R. N. et al. Metodologia para avaliação de plantas com atividade no sistema nervoso central e alguns dados experimentais. Revista Brasileira de Farmácia, v. 80, p. 72-76, 1999.

ALMEIDA, S. M. et al. Iron bioaccumulation in mycelium of Pleurotus ostreatus. Brazilian Journal of Microbiology, v. 46, p. 195-200, 2015.

CARDOSO, T. et al. Neuroprogression and cognitive functioning in bipolar disorder: a systematic review. Current psychiatry reports, v. 17, n. 9, p. 1-24, 2015.

CHAPMAN, K. L. et al. Pharmaceutical toxicology: designing studies to reduce animal use, while maximizing human translation. Regulatory Toxicology and Pharmacology, v. 66, n. 1, p. 88-103, 2013.

CHI-TSO, C. H. I. U.; CHUANG, D.M. Neuroprotective action of lithium in disorders of the central nervous system. Zhong nan da xue xue bao. Yi xue ban= Journal of Central South University. Medical sciences, v. 36, n. 6, p. 461-476, 2011.

CLARK, M.; STEGER-HARTMANN, T. A big data approach to the concordance of the toxicity of pharmaceuticals in animals and humans. Regulatory Toxicology and Pharmacology, v. 96, p. 94-105, 2018.

FARIA, M. G. I. et al. Lithium bioaccumulation in Lentinus crinitus mycelial biomass as a potential functional food. Chemosphere, v. 235, p. 538-542, 2019.

GOH, J.Y. et al. Development and use of in vitro alternatives to animal testing by the pharmaceutical industry 1980–2013. Toxicology Research, v. 4, n. 5, p. 1297-1307, 2015.

HILALY, J. E.; ISRAILI, Z. H.; LYOUSSI, B. Acute and chronic toxicological studies of Ajuga iva in experimental animals. Journal of ethnopharmacology, v. 91, n. 1, p. 43-50, 2004.

KENDRICK, J. et al. A novel welfare and scientific approach to conducting dog metabolism studies allowing dogs to be pair housed. Laboratory Animals, v. 54, n. 6, p. 588-598, 2020.

KIM, Y. et al. Molecular mechanisms of bipolar disorder: progress made and future challenges. Frontiers in cellular neuroscience, v. 11, p. 30, 2017.

LIMA, D. A. et al. Safety assessment of MEFAS: an innovative hybrid salt of mefloquine and artesunate for malaria treatment. Drug and Chemical Toxicology, v. 44, n. 4, p. 380-385, 2021.

MARCANTE, R. C. et al. Bioacumulação de zinco em micélio de Agaricus subrufescens. Arquivos de Ciências Veterinárias e Zoologia da UNIPAR, v. 17, n. 4, 2014.

MATSUZAWA, T. et al. Selection of appropriate parameters, use of a quality control concept, and suitable statistical analyses for clinical pathology examination of animals in toxicity studies: results of a current survey by the Japanese Pharmaceutical Manufacturers Association. Comparative Haematology International, v. 5, n. 3, p. 196-200, 1995.

MATUTE, R. G. et al. Copper and zinc bioaccumulation and bioavailability of Ganoderma lucidum. Journal of Medicinal Food, v. 14, n. 10, p. 1273-1279, 2011.

MENIQUETI, A. B. et al. Iron-enriched mycelia of edible and medicinal basidiomycetes. Environmental Technology, p. 1-7, 2020.

ORUCH, R. et al. Lithium: a review of pharmacology, clinical uses, and toxicity. European journal of pharmacology, v. 740, p. 464-473, 2014.

PERCIE DU SERT, N. et al. Reporting animal research: Explanation and elaboration for the arrive guidelines 2.0. PLoS Biology, v. 18, n. 7, p. 1-65, 2020.

STARK, Y. et al. Application of collagen matrices for cartilage tissue engineering. Experimental and Toxicologic Pathology, v. 57, n. 4, p. 305-311, 2006.

PRIOR, H. et al. Justification for species selection for pharmaceutical toxicity studies. Toxicology Research, v. 9, n. 6, p. 758-770, 2020.

SCHEID, S. S. et al. Iron biofortification and availability in the mycelial biomass of edible and medicinal basidiomycetes cultivated in sugarcane molasses. Scientific reports, v. 10, n. 1, p. 1-6, 2020.

SMITH, K. A.; CIPRIANI, A. Lithium and suicide in mood disorders: updated meta‐review of the scientific literature. Bipolar Disorders, v. 19, n. 7, p. 575-586, 2017.

SOUZA, M. M. Q. et al. Baccharis trimera (Less.) DC: an innovative cardioprotective herbal medicine against multiple risk factors for cardiovascular disease. Journal of Medicinal Food, v. 23, n. 6, p. 676-684, 2020.

SPOONER, N. et al. Microsampling: considerations for its use in pharmaceutical drug discovery and development. Bioanalysis, v. 11, n. 10, p. 1015-1038, 2019.

UMEO, S. H. et al. Iron or zinc bioaccumulated in mycelial biomass of edible basidiomycetes. Anais da Academia Brasileira de Ciências, v. 92, 2020.

WARING, S. W.; WEBB, D. J.; MAXWELL, S. R. Lithium carbonate as a potential pharmacological vehicle: intravenous kinetics of single-dose administration in healthy subjects. European journal of clinical pharmacology, v. 58, n. 6, p. 431-434, 2002.

YILDIZ, A. et al. Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials. Neuropsychopharmacology, v. 36, n. 2, p. 375-389, 2011.

YOKOTA, M. E. et al. Iron translocation in Pleurotus ostreatus basidiocarps: production, bioavailability, and antioxidant activity. Genetics and Molecular Research, v. 15, n. 1, p. 1-10, 2016.

Downloads

Publicado

2022-03-02

Como Citar

Silva, G. R. da, Amaral, E. C., Silva, M. L. M. ., Silva, A. O. ., da Silva, L. I. ., Froehlich, D. L. ., Faria, M. G. I., Linde, G. A. ., Colauto, N. B. ., Wietzikoski Lovato, E. C. ., & Lívero, F. A. dos R. (2022). Acute safety assessment of lithium bioacummulated in mycelial biomass of Ganoderma lucidum. Conjecturas, 22(2), 322–337. https://doi.org/10.53660/CONJ-644-611

Edição

Seção

Artigos